Drug groups
Drugs
Purpose of use in COVID-19
Hypersensitivity reactions
ST, DPT
BAT/ LTT
Desensitization
Antiviral drugs Favipiravir Viral pneumonia None
Lopinavir/Ritonavir AGEP58, MPE 57
Darunavir/Ritonavir
MPE63 Vesiculobullous lesions45,61
DNIHR 63,64
Umifenovir (Arbidol) None
Ribavirin
Pruritus43,52 Eczema43,50-52 Urticaria55 MPE53
DPT53
LTT54
DNIHR 55,56
Remdesivir (GS-5734) MPE48
Oseltamivir
Anaphylaxis65 SJS/TEN46, TEN47
SPT65
LTT47
Immunomodulatory drugs
Azithromycine
MPE70,71, ACD72,73, FDE74 AGEP75, DRESS76 SJS77,78 Anaphylaxis69 Urticaria68 Leucocytoclastic vasculitis79 Hypersensitivity myocarditis80 PT72 SPT81,82, IDT81,82 DPT84
DIHR85
Hydroxychloroquine / Chloroquine
MPE87, AGEP89,100, DRESS90-92 Erythema multiforme93 Bullous erythema94 SJS/TEN96,97 Photoallergic dermatitis98 ACD99 Anaphylaxis106,107 PT93,95,100 DPT87 SPT106 DNIHR101-105 DIHR106,107
Auranofin None
Interferons
Local reaction113 Urticaria116,119,120 Eczema116, FDE117, MPE116 Anaphylaxis121,122 IDT116,123 SPT119-121 PT116 DPT122 DIHR120 DNIHR 116,124
Nitazoxanide None
Ivermectin
FDE126, DRESS127 SJS128, TEN129